CIK: 0001536054 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value ($000): $62,563 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| DNLI | DENALI THERAPEUTICS INC | 3,860,732 | $54,012 | 86.3% | $33.82 | -58.4% | COM | 24823R105 |
| SANA | SANA BIOTECHNOLOGY INC | 2,420,937 | $6,609 | 10.6% | $21.17 | -90.3% | COM | 799566104 |
| EGHT | 8X8 INC NEW | 990,580 | $1,942 | 3.1% | $4.02 | -56.1% | COM | 282914100 |